• Policy & Insight

Opinion: ‘We need to increase testing in primary care’

Professor Willie Hamilton specialises in primary care diagnostics at the University of Exeter, with a particular expertise in cancer. Professor Willie Hamilton specialises in primary care diagnostics at the University of Exeter, with a particular expertise in cancer.

24 February 2021

• Policy & Insight

Opinion: 'We’re making headway, but we can’t be complacent'

We published our gender and ethnicity pay gap reports today. We published our gender and ethnicity pay gap reports today.

11 February 2021

• Policy & Insight

Opinion: 'Why we need earlier diagnosis of cancer more than ever before'

Professor Georgios Lyratzopoulos leads the Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group and CanTest at University College London. Professor Georgios Lyratzopoulos leads the Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group and CanTest at University College London.

3 February 2021

• Health & Medicine
• Policy & Insight

Opinion: 'Beating cancer means beating it for everyone'

We’ve long felt that Cancer Research UK has a role to play in tackling inequalities, writes Michelle Mitchell. We’ve long felt that Cancer Research UK has a role to play in tackling inequalities, writes Michelle Mitchell.

29 January 2021

• Policy & Insight
• Science & Technology

We have a Deal: What does the new UK-EU relationship mean for cancer?

Here’s what we know about how the new UK-EU relationship may affect cancer services and research. Here’s what we know about how the new UK-EU relationship may affect cancer services and research.

4 January 2021

• Policy & Insight

Opinion: "There's cause for optimism in 2021 and beyond"

COVID-19 changed so much of our plans, but it didn’t change everything. In this dark year, there were still pockets of light, writes our CEO Michelle Mitchell. COVID-19 changed so much of our plans, but it didn’t change everything. In this dark year, there were still pockets of light, writes our CEO Michelle Mitchell.

30 December 2020

• Science & Technology
• Policy & Insight

What could DeepMind ‘solving’ the protein folding problem mean for cancer research?

We asked two of our protein specialists, who are trying to understand how the way proteins fold affect cancer outcomes, to give their verdict on the news. We asked two of our protein specialists, who are trying to understand how the way proteins fold affect cancer outcomes, to give their verdict on the news.

23 December 2020

• Policy & Insight

Beating cancer by improving the public’s health: the road ahead in England

Public Health England could be disbanded by March 2021. Here's what's at stake for cancer. Public Health England could be disbanded by March 2021. Here's what's at stake for cancer.

4 December 2020

• Policy & Insight

Opinion: ‘We can’t afford to stop now’

Last week, the UK Government announced what it would spend money on next year. Overall, the results were a mixed bag – but a step in the right direction, writes Michelle Mitchell. Last week, the UK Government announced what it would spend money on next year. Overall, the results were a mixed bag – but a step in the right direction, writes Michelle Mitchell.

30 November 2020

• Policy & Insight

Spending Review 2020: Steps in the right direction, but opportunities missed

Today, the Chancellor set out the UK Government’s spending priorities for the next year. Here’s what was announced today and what it could mean for cancer. Today, the Chancellor set out the UK Government’s spending priorities for the next year. Here’s what was announced today and what it could mean for cancer.

25 November 2020

• Policy & Insight

Why the voices of people affected by cancer are critical to our work, now more than ever

Our network members are amazing, and we’ve done some brilliant work together, writes our director of information and involvement. Our network members are amazing, and we’ve done some brilliant work together, writes our director of information and involvement.

23 November 2020

• Health & Medicine
• Policy & Insight

Learning the lessons of COVID-19: Protecting cancer services and research through the pandemic

We're calling on UK governments to stand by their commitments to improving cancer survival and make sure everyone can receive the care they deserve. We're calling on UK governments to stand by their commitments to improving cancer survival and make sure everyone can receive the care they deserve.

9 November 2020